REFRACTORY MYELOPROLIFERATIVE NEOPLASM

Clinical trials for REFRACTORY MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for REFRACTORY MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This study is testing a new combination of two drugs, axatilimab and azacitidine, for people with advanced or hard-to-treat blood cancers. The first part of the study aims to find the safest and most effective dose. The second part will see how well the drug combination works to …

Matched conditions: REFRACTORY MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

REFRACTORY MYELOPROLIFERATIVE NEOPLASM

Get alerted when new REFRACTORY MYELOPROLIFERATIVE NEOPLASM trials appear

New drug combo tested for Tough-to-Treat blood cancers